FDA
-
-
-
-
-
-
-
STERIS Announces Outcome of Ethylene Oxide Trial
-
-
-
-
-
-
-
STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024
-
-
-
-
-
-
-
STERIS Announces Dividend of $0.52 per share
-
-
-
-
-
-
-
STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD
-
-
-
-
-
-
-
STERIS Announces $500 million Share Repurchase Authorization and Declares $0.47 per share Dividend
-
-
-
-
-
-
-
STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023
-
-
-
-
-
-
-
STERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022
-
323,147 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

